IFNA1 and COVID-19: In a recent study that compared the immune profiles between patients with severe respiratory INFL illness and moderate/severe COVID-19 patients, CSS was found to be relatively rare among moderate and severe COVID-19 infections, with most COVID-19 patients to exhibit suppressed immune profiles, mainly noticeable in IFN signaling, relative to those detected in INFL patients (22).